Loading...
Micro Labs Limited — Ornidazole Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #2 for Ornidazole · $4.0M export value · DGFT Verified
Micro Labs Limited is the #2 Indian exporter of Ornidazole with $4.0M in export value and 181 verified shipments. Micro Labs Limited holds a 22.4% market share in Ornidazole exports across 15 countries. The company exports 76 pharmaceutical products worth $463.6M across 21 therapeutic categories.
| Country | Value | Shipments | Share |
|---|---|---|---|
| FRANCE | $1.4M | 52 | 40.6% |
| MADAGASCAR | $565.3K | 37 | 16.1% |
| UGANDA | $432.3K | 15 | 12.3% |
| KENYA | $350.8K | 17 | 10.0% |
| NIGERIA | $333.6K | 17 | 9.5% |
| MAURITIUS | $147.8K | 16 | 4.2% |
| RUSSIA | $107.8K | 4 | 3.1% |
| FINLAND | $60.5K | 2 | 1.7% |
| PHILIPPINES | $36.7K | 3 | 1.0% |
| RWANDA | $24.8K | 10 | 0.7% |
Micro Labs Limited exports Ornidazole to 16 countries. The largest destination is FRANCE accounting for 40.6% of Micro Labs Limited's Ornidazole shipments, followed by MADAGASCAR (16.1%) and UGANDA (12.3%). These destinations reflect Micro Labs Limited's established distribution network and regulatory approvals in key markets.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| E.P.DIS | FRANCE | $889.6K | 30 |
| LABOREX UGANDA LIMITED | UGANDA | $583.7K | 20 |
| E P DIS | FRANCE | $375.6K | 16 |
| MICRO NOVA PHARMACEUTICALS IND | NIGERIA | $283.2K | 13 |
| SOMAPHAR | MADAGASCAR | $209.6K | 11 |
India exported $8.9M worth of Ornidazole through 1,175 shipments from 249 suppliers to 83 countries, serving 439 buyers globally. Micro Labs Limited contributes $4.0M to this total, accounting for 22.4% of India's Ornidazole exports. Micro Labs Limited ships Ornidazole to 16 countries through 40 buyers.
Micro Labs Limited's average Ornidazole shipment value is $21.9K per consignment, based on 181 shipments totaling $4.0M. The largest destination is FRANCE (40.6% of Micro Labs Limited's Ornidazole exports).
Micro Labs Limited ranks #2 among 249 Indian Ornidazole exporters with a 22.4% market share. The top 3 exporters are MICRO LABS LIMITED ($4.0M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($1.4M), LINCOLN PHARMACEUTICALS LTD ($700.0K). Micro Labs Limited processed 181 shipments to 15 destination countries.
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| ORNILOX (ORNIDAZOLE 500MG & OFLOXACIN 20 | $246.9K | 12 |
| ORNILOX ( (Ornidazole 500mg & Ofloxacin | $207.0K | 10 |
| ORNILOX ( (Ofloxacin + Ornidazole Tablet | $187.5K | 5 |
| ORNILOX (ORNIDAZOLE 500MG + OFLOXACIN 20 | $124.8K | 5 |
| ORNILOX ( (Ornidazole 500mg & Ofloxacin200mg Tablets) ) ( 1X10S ) ( QTY- 18032000 ) | $100.0K | 2 |
| COMBIFLOX (ORNIDAZOLE 500MG + OFLOXACIN | $86.2K | 3 |
| ORNILOX ( (ORNIDAZOLE 500MG & OFLOXACIN200MG TABLETS) ) ( 1X10'S ) | $85.9K | 3 |
| ORNILOX ( (Ornidazole 500mg + Ofloxacin | $70.8K | 3 |
| ORNILOX Ornidazole 500mg & Ofloxacin200mg Tablets 1X10S QTY- 7790.000 |
Exporters ranked immediately above and below #2 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | MICRO LABS LIMITED ★ | $4.0M | 181 | 15 | $21.9K |
| 3 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $1.4M | 30 | 7 | $47.7K |
| 1 | LINCOLN PHARMACEUTICALS LTD | $700.0K | 14 | 5 | $50.0K |
Micro Labs Limited ranks #2 among 249 Indian Ornidazole exporters. Average shipment value of $21.9K compared to the market average of $35.6K. The closest competitors by value are SUN PHARMACEUTICAL INDUSTRIES LIMITED and LINCOLN PHARMACEUTICALS LTD.
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 118 | 10.0% |
| JNPT/ NHAVA SHEVA SEA | 77 | 6.6% |
| DELHI AIR CARGO ACC (INDEL4) | 75 | 6.4% |
| DELHI AIR | 69 | 5.9% |
| SAHAR AIR CARGO ACC (INBOM4) | 66 | 5.6% |
| SAHAR AIR | 60 | 5.1% |
| JNPT | 58 | 4.9% |
| BANGALORE ACC (INBLR4) | 53 | 4.5% |
Visual overview of India's ornidazole supplier profile for Micro Labs Limited — top suppliers, destinations, pricing, and trade routes
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Micro Labs Limited. The Israel-Iran conflict has intensified tensions in the Red Sea, leading to increased shipping costs and potential delays. These disruptions can affect supply chain efficiency and profitability, necessitating strategic adjustments in logistics and distribution channels.
Conversely, the U.S.-China trade tensions have prompted the United States to diversify its pharmaceutical supply sources, creating an opportunity for Indian exporters to capture a larger market share. Micro Labs can leverage this shift by emphasizing its compliance with U.S. regulatory standards and ensuring a reliable supply chain.
The recent India-European Union Free Trade Agreement, signed in January 2026, is poised to eliminate tariffs on most European pharmaceutical exports to India. While this enhances market access for European manufacturers, it also intensifies competition for Indian exporters. Micro Labs must enhance its value proposition through innovation, cost efficiency, and adherence to EU regulatory standards to maintain its competitive edge. (en.wikipedia.org)
Compliance with international regulatory standards is paramount for pharmaceutical exporters. Micro Labs Limited has demonstrated a commitment to quality, as evidenced by its recognition as India’s Most Technically and Scientifically Advanced Pharmaceutical Manufacturing Company in 2024. This accolade reflects the company's adherence to stringent manufacturing practices and international guidelines. (einnews.com)
However, the evolving regulatory landscape, including the EU's Falsified Medicines Directive and the U.S. FDA's stringent quality requirements, necessitates continuous investment in compliance infrastructure. Micro Labs must proactively adapt to these changes to ensure uninterrupted market access and maintain its reputation for quality.
Micro Labs Limited exports 76 products worth $463.6M. Beyond Ornidazole, top products include Amoxicillin, Potassium, Gabapentin, Losartan, Esomeprazole. View the complete Micro Labs Limited profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Ornidazole — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Micro Labs Limited's Ornidazole exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Micro Labs Limited
Full Company Profile →
76 products · $463.6M total trade · 21 categories
| E.P.DIS.,., | FRANCE | $162.2K | 6 |
| OOO LIFE CELL LTD | RUSSIA | $107.8K | 3 |
| M/S LABOREX KENYA LIMITED | KENYA | $106.4K | 6 |
| SOMAPHAR. | MADAGASCAR | $100.0K | 2 |
| OFFICE PHARMACEUTIQUE MALGACHE S.A. | MADAGASCAR | $92.5K | 10 |
Micro Labs Limited supplies Ornidazole to 40 buyers globally. The largest buyer is E.P.DIS (FRANCE), followed by LABOREX UGANDA LIMITED (UGANDA) and E P DIS (FRANCE). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
| $54.2K |
| 2 |
| ORNILOX ( (Ofloxacin 200mg + Ornidazole | $50.6K | 2 |
Micro Labs Limited exports 134 distinct Ornidazole formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ORNILOX (ORNIDAZOLE 500MG & OFLOXACIN 20 with 12 shipments worth $246.9K.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 83+ countries, 439+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Micro Labs Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ornidazole. For current shipment-level data, contact TransData Nexus.